Cyclophosphamide-d4
如果您对该产品感兴趣的话,可以
产品名称:
Cyclophosphamide-d4
产品型号:
GOY-Y2305
产品展商:
谷研
产品文档:
无相关文档
发布时间:2023-04-27
简单介绍
Cyclophosphamide-d4Chloroform: Slightly Soluble,Methanol: Slightly Soluble
Cyclophosphamide-d4
的详细介绍
|
性能参数
|
|
产品名称
|
Cyclophosphamide-d4
|
|
规格
|
1 mg
|
|
货号
|
GOY-Y2305
|
|
含量
|
>99.00%
|
|
CAS
|
173547-45-0
|
|
别名
|
N/A
|
|
|
|
化学名
|
N/A
|
分子式
|
C7H11Cl2D4N2O2P
|
|
分子量
|
分子 265.1
|
溶解度
|
Chloroform: Slightly Soluble,Methanol: Slightly Soluble
|
|
储存条件
|
Store at -20°C
|
General tips
|
|
|
用途
|
仅供科研
|
价格
|
电询
|
|
|
|
详细内容
|
1.Yildirim-Toruner, C., and Diamond, B.Current and novel therapeutics in the treatment of systemic lupus erythematosusJ. Allergy Clin. Immunol.127(2)303-314(2011) 2.Appel, G.B.New and future therapies for lupus nephritisCleve. Clin. J. Med.79(2)134-140(2012) 3.Ahmed, A.R., and Hombal, S.M.Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical usesJ. Am. Acad. Dermatol.11(6)1115-1126(1984) 4.Bischoff, P.L., Holl, V., Coelho, D., et al.Apoptosis at the interface of immunosuppressive and anticancer activities: The examples of two classes of chemical inducers, oxysterols and alkylating agentsCurr. Med. Chem.7(7)693-713(2000)
|
公司正在销售的产品：
|
霉菌液体培养基 BR 甘氨酸 药典级，Ph. Eur., BP, USP, 99-101%
麦芽浸膏汤 BR 甘氨酸 用于电泳, ≥99%
MUGal肉汤 BR 甘氨酸 用于分子生物学, ≥99.0% (NT
改良E.C新生霉素增菌肉汤基础 BR L-组氨酸 99%
MFC培养基 BR L-赖氨酸 98%
甘露醇发酵培养基 BR 变色酸2R AR
|
MRX-2843 (UNC2371)1mg 5mg 10mg 25mg 50mg>98.00%Cas No. 1429882-07-4C29H40N6O
Motesanib Diphosphate (AMG-706)10mM (in 1mL DMSO) 10mg 25mg 50mg 100mg>98.00%Cas No. 857876-30-3C22H23N5O.2H3PO4
Mobocertinib10 mg 25 mg 50 mg 100 mg 500 mg>98.00%Cas No. 1847461-43-1C32H39N7O4
MID-15 mg 10 mg 25 mg 50 mg 100 mg>98.00%Cas No. 312608-54-1C12H11N3O4S
Nazartinib mesylate2mg 5mg 10mg 50mg 100mg>98.00%Cas No. 1508250-72-3C27H35ClN6O5S
Naquotinib mesylate (ASP8273)5mg 10mg 25mg 50mg 100mg>98.00%Cas No. 1448237-05-5C31H46N8O6S
Naquotinib (ASP8273)1mg 5mg 10mg 25mg 50mg>98.00%Cas No. 1448232-80-1C30H42N8O3
|